查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
動物狂犬病疫苗市場規模、份額和趨勢分析報告：按應用（伴侶動物、家畜、野生動物）、地區、分部預測，2023-2030 年
市場調查報告書
商品編碼
1178707

動物狂犬病疫苗市場規模、份額和趨勢分析報告：按應用（伴侶動物、家畜、野生動物）、地區、分部預測，2023-2030 年

Rabies Veterinary Vaccines Market Size, Share & Trends Analysis Report By Application (Companion Animals, Livestock Animals, Wildlife Animals), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

動物狂犬病疫苗市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球獸用狂犬病疫苗市場預計將達到 8.025 億美元。從 2023 年到 2030 年，該市場預計將以 4.1% 的複合年增長率增長。推動市場的關鍵因素包括提高對人畜共患疾病的認識、提高流浪動物的疫苗接種率，以及政府加大力度推動到 2030 年消滅狂犬病。推動動物狂犬病疫苗接種市場的主要因素之一是對牲畜疫苗的認識和教育。有許多疫苗獲批用於牲畜，包括滅活病毒載體產品、減毒病毒載體產品、IM 和 SC 注射產品、持續時間為 1-3 年的產品以及最低接種年齡的產品。定期的公共教育、負責任的寵物護理、定期的獸醫治療和疫苗接種以及持續的專業培訓是狂犬病預防和控制的關鍵組成部分。

是預防和控制狂犬病的重要因素。通過傳播有關狂犬病傳播途徑的知識，避免與野生動物接觸和為野生動物接種狂犬病疫苗的需求將廣泛傳播，極大地有助於控制野生動物的感染傳播。此外，疫苗接種可改善牲畜的總體狀況，從而降低全因死亡率。

狂犬病是一種攻擊中樞神經系統的致命性疾病，一旦出現臨床症狀就沒有有效的治療方法。據估計，狗的狂犬病在全球造成 860 萬美元的損失，佔每年發生的大約 60,000 例狂犬病死亡總數的 98%。在過去的 50 年裡，美國為根除動物和人類狂犬病做出了重大努力。由於動物大規模疫苗接種方法的發展和散養規定的實施，感染狗傳狂犬病的動物數量已從每年高達 10,000 例減少。儘管取得了這些進展，狂犬病仍然是一個主要的公共衛生威脅，在美國各地野生動物喬木中的浣熊、臭鼬和狐狸中流行。

在世界各地，COVID-19 大流行正在擾亂關鍵的衛生服務。為加速實現這一目標，聯合抗狂犬病論壇於 2020 年成立，以倡導“同一個健康”戰略。全球狂犬病戰略的關鍵要素包括社區參與、改善人類狂犬病疫苗的獲取以及增加對狗的大規模疫苗接種。狂犬病消除策略的進展可以用作服務不足人群獲得醫療保健公平性的指標，也可以用作“同一個健康”成功的早期指標。對狗進行大規模疫苗接種是全球消除狂犬病戰略的核心，目標是達到 70% 的覆蓋率。大多數流行國家在分配、數量減少和進口犬疫苗方面遇到了困難。這是因為犬用疫苗最初並未列入必要項目清單。即使在讚比亞等本地製造的國家，預算限制也阻礙了犬疫苗的生產。

即使在像贊比亞這樣在當地生產的國家，由於預算限制，他們也無法生產狗疫苗。

狂犬病通過唾液傳播，並可通過被受感染的動物咬傷而傳播。狂犬病也可以通過猴子、狗、蝙蝠甚至貓傳播。印度尼西亞 98% 的狂犬病病例都是由被狂犬病犬咬傷引起的。根據 2021 年 12 月發表的國家醫學圖書館論文，全球動物狂犬病病例數在過去十年中略有增加。在泰國，2017-2018 年，描述動物狂犬病的特徵，使用廣義相加模型評估每月狂犬病發病率與可理解因素之間的關係，並估計狂犬病流行的地理風險區域。進行了一項研究以一項調查顯示，狗是泰國最常感染狂犬病的疾病。大多數被感染的狗是家養狗，自由活動，沒有接種疫苗。東北地區的狂犬病感染人數最多，其次是中部地區和東北地區。

區域。短期來看，從6月開始逐漸增加，2018年1月開始明顯增加。在這些狂犬病流行國家，正在採取強有力的措施，例如狗的群體免疫項目、餵養野生動物的狂犬病疫苗接種運動以及對寵物進行強制性狂犬病疫苗接種，從而促進市場的增長。預計

動物狂犬病疫苗市場報告要點

由於多個國家對寵物強制接種狂犬病疫苗、狗的大規模疫苗接種計劃基本到位以及狗擁有量顯著增加，伴侶動物部門將在 2022 年增長到最大值。佔收入份額

由於發達地區野生動物狂犬病疫苗接種活動的增加，野生動物行業預計在預測期內以 4.4% 的最快複合年增長率增長

預計北美在預測期內將保持領先地位。這是由於該地區人均動物保健支出高和寵物擁有率高。美國幾乎每個州都強制要求對寵物進行常規狂犬病疫苗接種，以期在不久的將來根除狂犬病。

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
    • 估計/預測時間表
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查：
    • 第一次調查的內容
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
  • 二級信息列表
  • 目的

第二章執行摘要

  • 2022 年市場概況（百萬美元）
  • 段快照
  • 爭用快照

第三章動物狂犬病疫苗市場：市場變量的趨勢和範圍

  • 市場系列展望
    • 母市場分析
    • 補充市場分析
  • 繪製滲透率和增長前景
  • 市場動態
    • 市場驅動力分析
    • 市場約束因素分析
    • 市場機會分析
    • 市場問題分析
  • 行業分析
    • 波特五力分析
      • 買方議價能力
      • 供應商的議價能力
      • 新進入者的威脅
      • 替代品的威脅
      • 行業競爭力：高
    • PESTEL 分析
      • 政治和法律環境
      • 經濟社會形勢
      • 環境狀況
      • 科技景觀
  • 2018 年至 2022 年按主要物種和主要國家分列的估計動物種群數量
  • 按地區和主要國家劃分的東盟狂犬病病例估計數
  • 東盟地區及主要國家的狂犬病疫苗接種率（覆蓋率）估計
  • 按地區分列的東盟狂犬病死亡率估計值
  • 監管框架
  • COVID-19 影響分析
    • 當前和未來的影響分析
    • COVID-19 對市場參與者的影響

第四章動物狂犬病疫苗市場：應用分析

  • 2022 年和 2030 年應用市場份額分析
  • 動物狂犬病疫苗市場：應用波動分析，2018-2030
  • 伴侶動物
    • 家畜
    • 野生動物

第五章動物狂犬病疫苗市場：區域市場應用分析，2018-2030（百萬美元）

  • 2022 年和 2030 年區域市場份額分析
  • 區域市場快照
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 波蘭
    • 俄羅斯
    • 羅馬尼亞
    • 土耳其
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第六章動物狂犬病疫苗市場——競爭格局

  • Merck & Co., Inc. (MSD Animal Health)
  • Indian Immunologicals Ltd.
  • Boehringer Ingelheim International GmbH (Animal Health)
  • Zoetis
  • Virbac
  • BroadChem Philippines Biopharma Corporation
  • Elanco
  • Ceva
  • BiogenesisBago
  • 參賽者概覽
  • 財務績效
  • 進入公司
    • 市場領導者
    • 戰略規劃
  • 私人公司名單
Product Code: GVR-4-68040-011-9

Rabies Veterinary Vaccines Market Growth & Trends:

The global rabies veterinary vaccines market size is expected to reach USD 802.5 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.1% from 2023 to 2030. The key factors driving the market include an increase in zoonotic disease awareness, boosting stray animal immunization coverage, and growing number of government initiatives with the motive of eradicating rabies by 2030. One of the main drivers propelling the market for animal rabies vaccinations is domestic animal vaccine awareness and education. There are numerous vaccines approved for use in domestic animal species, which include inactivated and modified-live virus vector products, products for IM and SC injection, products with immunization durations ranging from 1 to 3 years, and products with a range of minimum vaccination ages. Regular public education, responsible pet ownership, routine veterinary treatment and vaccinations, and continuous professional training are crucial element

s of rabies prevention and control. By spreading knowledge about rabies transmission channels, the necessity of avoiding contact with wildlife and vaccinating wildlife with bait rabies vaccines are widely initiated, which greatly helps in reducing the spread of the disease from wildlife sources. Additionally, the vaccination improves domestic animals' general health and is linked to a decline in all-cause mortality rates.

Rabies is a deadly disease that attacks the central nervous system and has no effective treatment once clinical signs appear. It is estimated that 8.6 million dollars are spent globally on canine rabies, which is responsible for 98% of approximately 60,000 total rabies deaths that occur each year. The U.S. has made enormous efforts over the past 50 years to eradicate rabies in both animal and human populations. The number of animals infected with canine-mediated rabies has decreased from up to 10,000 cases per year because of the development of mass animal vaccination procedures and the enforcement of leash restrictions. Despite these developments, rabies continues to pose a major threat to public health and is still prevalent in raccoons, skunks, and foxes in wildlife reservoirs throughout the U.S.

All around the world, the COVID-19 pandemic has disrupted crucial health services. The United Against Rabies Forum, which advocates a 'One Health' strategy, was established in 2020 to hasten the achievement of this objective. The main components of the global rabies strategy include community involvement, better access to human rabies vaccines, and expanded mass dog vaccination. The advancement of rabies eradication strategies can be used as a marker for the equity of healthcare access in underserved populations and as an early indicator for the successful implementation of 'One Health'. The core element of the global rabies elimination strategy is mass dog vaccination, with a 70% coverage rate as the goal. The majority of endemic nations saw difficulties with distribution, volume reductions, and importation delays for dog vaccines. This was because dog vaccines initially did not fit within the category of necessary items. Budget restrictions prevented the production of dog vaccines even in countries such as Zambia where they are made locally.

Rabies is spread through saliva, which means the infection can be transmitted through infected animal bites. Rabies can be transmitted by monkeys, dogs, bats, or, in some cases, cats. 98% of rabies cases in Indonesia are caused by rabid dog bites. According to an article published in December 2021, by the National Library of Medicine over the past 10 years, there has been a slight increase in the number of animal rabies cases globally. In Thailand, a study was conducted between 2017 and 2018 to identify the characteristics of animal rabies, assess the relationship between monthly rabies incidence and understandable factors using generalized additive models, and estimate the geographical risk areas for rabies spread. According to the study, dogs are the most common species in Thailand that are infected by rabies. The majority of the infected dogs were owned, roaming freely, and were not vaccinated. The northeast region of the country has the highest concentrations of rabies cases, followed by the middle and so

uthern regions. In the short term, the number of cases increased gradually after June and significantly from January in 2018. Such rabies-endemic countries are taking strong measures such as dog mass vaccination programs, wildlife bait rabies vaccination campaigns, and mandatory pet rabies vaccinations among others, which are anticipated to fuel the growth of the market.

Rabies Veterinary Vaccines Market Report Highlights:

  • The companion animals segment held the largest revenue share in 2022 owing to the mandatory pet rabies vaccinations regulated in several countries, largely conducted mass dog vaccination programs, and significantly rising dog ownership rates
  • The wildlife animals segment is anticipated to expand at the fastest CAGR of 4.4% over the forecast period owing to the rising wildlife rabies vaccination campaigns in developed regions
  • North America is expected to maintain its lead over the forecast period. This is due to the region's high per capita animal healthcare spending and a large number of pet ownership rates. Almost every state in the U.S. mandates regular rabies vaccination for pets with the mission of eradicating rabies in the near future

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates & Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary Research:
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
  • 1.7 List of Secondary Sources
  • 1.8 Objectives

Chapter 2 Executive Summary

  • 2.1 Market Snapshot, 2022 (USD Million)
  • 2.2 Segment Snapshot
  • 2.3 Competitive Snapshot

Chapter 3 Rabies Veterinary VaccinesMarket: Market Variables Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
    • 3.3.2 Market Restraint Analysis
    • 3.2.3 Market Opportunity Analysis
    • 3.2.4 Market Challenge Analysis
  • 3.4 Industry Analysis
    • 3.4.1 Porter's 5 Forces Analysis
      • 3.4.1.1 Bargaining Power of Buyers
      • 3.4.1.2 Bargaining Power of Suppliers
      • 3.4.1.3 Threat of New Entrants
      • 3.4.1.4 Threat of Substitutes
      • 3.4.1.5 Industry Rivalry: High
    • 3.4.2 Pestel Analysis
      • 3.4.2.1 Political & Legal Landscape
      • 3.4.2.2 Economic & Social Landscape
      • 3.4.2.3 Environmental Landscape
      • 3.4.2.4 Technology Landscape
  • 3.5 Estimated Animal Population by Key Species and Key Countries, 2018-2022
  • 3.6 ASEAN Estimated Rabies Patient Volumes, by Region & Key Countries
  • 3.7 ASEAN Estimated Spread Rate (Coverage) of Rabies Vaccination, by Region & Key Countries
  • 3.8 ASEAN Estimated Rabies Mortality Rate, by Region
  • 3.9 Regulatory Framework
  • 3.10 COVID-19 Impact Analysis
    • 3.10.1 Current and Future Impact Analysis
    • 3.10.2 Impact of COVID-19 on Market Players

Chapter 4 Rabies Veterinary VaccinesMarket: Application Analysis

  • 4.1 ApplicationMarket Share Analysis, 2022 & 2030
  • 4.2 Rabies Veterinary VaccinesMarket: Application movement Analysis, 2018 to 2030
  • 4.3 Companion Animals
    • 4.3.1 Companion animalsMarket estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.2 Livestock Animals
      • 4.3.2.1 Livestock animals Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.3 Wildlife Animals
      • 4.3.3.1 Wildlife animals Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5 Rabies Veterinary Vaccines Market: Regional Market Analysis, By Application, 2018 - 2030 (USD Million)

  • 5.1 Regional Market Share Analysis, 2022& 2030
  • 5.2 Regional Market Snapshot
  • 5.3 North America
    • 5.3.1 North America Rabies Veterinary Vaccines Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 5.3.2 U.S.
      • 5.3.2.1 U.S. Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.3 Canada
      • 5.3.3.1 Canada Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4 Europe
    • 5.4.1 Europe Rabies Veterinary Vaccines Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 5.4.2 Poland
      • 5.4.2.1 Poland Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3 Russia
      • 5.4.3.1 Russia Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4 Romania
      • 5.4.4.1 Romania Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.5 Turkey
      • 5.4.5.1 Turkey Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.6 Spain
      • 5.4.6.1 Spain Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5 Asia Pacific
    • 5.5.1 Asia Pacific Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.2 Japan
      • 5.5.2.1 Japan Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.3 China
      • 5.5.3.1 China Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.4 India
      • 5.5.4.1 India Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.5 South Korea
      • 5.5.5.1 South Korea Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.6 Thailand
      • 5.5.6.1 ThailandRabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6 Latin America
    • 5.6.1 Latin America Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.2 Brazil
      • 5.6.2.1 Brazil Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.3 Mexico
      • 5.6.3.1 Mexico Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.4 Argentina
      • 5.6.4.1 Argentina Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7 MEA
    • 5.7.1 MEA Rabies Veterinary Vaccines Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 5.7.2 South Africa
      • 5.7.2.1 South Africa Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.3 Saudi Arabia
      • 5.7.3.1 Saudi Arabia Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.4 UAE
      • 5.5.4.1 UAE Rabies Veterinary Vaccines Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6Rabies Veterinary VaccinesMarket - Competitive Landscape

  • 6.1 Merck & Co., Inc. (MSD Animal Health)
  • 6.2 Indian Immunologicals Ltd.
  • 6.3 Boehringer Ingelheim International GmbH (Animal Health)
  • 6.4 Zoetis
  • 6.5 Virbac
  • 6.6 BroadChem Philippines Biopharma Corporation
  • 6.7 Elanco
  • 6.8 Ceva
  • 6.9 BiogenesisBago
  • 6.10 Participant's Overview
  • 6.11 Financial Performance
  • 6.12 Participant Categorization
    • 6.12.1 Market Leaders
    • 6.12.2 Strategy Mapping
  • 6.13 List of Private Players

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of key companies
  • Table 3. North America Rabies Veterinary Vaccines market, by country, 2018 - 2030 (USD Million)
  • Table 4. North America Rabies Veterinary Vaccines market, by application, 2018 - 2030 (USD Million)
  • Table 5. U.S. Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 6. Canada Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 7. Europe Rabies Veterinary Vaccines market, by country, 2018 - 2030 (USD Million)
  • Table 8. Europe Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 9. Poland Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 10. Russia Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 11. Romania Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 12. Turkey Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 13. Spain Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 14. Asia pacific Rabies Veterinary Vaccines market, by country, 2018 - 2030 (USD Million)
  • Table 15. Asia pacific Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 16. China Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 17. Japan Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 18. India Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 19. South Korea Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 20. Thailand Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 21. LATAM Rabies Veterinary Vaccines market, by country, 2018 - 2030 (USD Million)
  • Table 22. LATAM Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 23. Brazil Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 24. Mexico Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 25. Argentina Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 26. MEA Rabies Veterinary Vaccines market, by country, 2018 - 2030 (USD Million)
  • Table 27. MEA Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 28. South Africa Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 29. Saudi Arabia Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 30. UAE Rabies Veterinary Vaccines market, by Application, 2018 - 2030 (USD Million)
  • Table 31. Global Rabies Veterinary Vaccines market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 Rabies Veterinary Vaccines Market Application outlook: Key takeaways, 2022 & 2030
  • Fig. 15 Rabies Veterinary Vaccines Market: Application movement analysis
  • Fig. 16 Global companion animals market 2018 - 2030 (USD Million)
  • Fig. 17 Global livestock animals market 2018 - 2030 (USD Million)
  • Fig. 18 Global wildlife animals market 2018 - 2030 (USD Million)
  • Fig. 19 Regional outlook, 2022 & 2030
  • Fig. 20 Regional marketplace: Key takeaways
  • Fig. 21 North America Rabies Veterinary Vaccines Market by countries, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 23 Canada Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 24 Europe Rabies Veterinary Vaccines market by countries, 2018 - 2030 (USD Million)
  • Fig. 25 Poland Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 26 Russia Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 27 Romania Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 28 Turkey Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 29 Spain Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 30 Asia Pacific Rabies Veterinary Vaccines market by countries, 2018 - 2030 (USD Million)
  • Fig. 31 China Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 32 Japan Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 33 India Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 34 South Korea Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 35 Thailand Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 36 Latin America Rabies Veterinary Vaccines market by countries, 2018 - 2030 (USD Million)
  • Fig. 37 Brazil Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 39 Argentina Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 40 MEA Rabies Veterinary Vaccines market by countries, 2018 - 2030 (USD Million)
  • Fig. 41 South Africa Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 42 Saudi Arabia Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 43 UAE Rabies Veterinary Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 44 Market participant categorization
  • Fig. 45 Company market position analysis